Abstract
Introduction: Familial chylomicronemia syndrome is considered a rare autosomal recessive disorder that can clinically manifest from childhood but may occur at any age. Clinically, it presents with abdominal pain, recurrent acute pancreatitis, cutaneous xanthomas, and hepatosplenomegaly. Confirmation through NGS (Next-Generation Sequencing) is necessary to ensure that the identified variant is always biallelic. The parents, by definition, are heterozygous for the same variant and do not have the disease; they only carry the mutation without experiencing symptoms.
Objective: To investigate the presence of chylomicronemia and determine its inheritance pattern, whether it is a familial form with a biallelic monogenic pattern or a condition of multifactorial nature.
Case presentation: We present the case of a patient with multiple comorbidities who presents with abdominal pain and unexplained hypertriglyceridemia. Genetic studies are ordered to identify the etiology and establish appropriate treatment.
Discussion and conclusion: Genetic studies and molecular analysis are performed through next-generation sequencing, identifying homozygosity in the LMF1 gene, a variant known to be pathogenic. To diagnose chylomicronemia syndrome, nonpathogenic biallelic variants in the LPL complex and related proteins must be identified. Treatment involves dietary fat restriction to reduce morbidity and mortality, as well as genetic follow-up for studying at-risk family members.
References
Burnett JR, Hooper AJ, Hegele RA. Familial Lipoprotein Lipase Deficiency. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; October 12, 1999 [updated 2017 Jun 22]. https://pubmed.ncbi.nlm.nih.gov/20301485/
Dayar E, Pechanova O. Targeted strategy in lipid-lowering therapy. Biomedicines. 2022;10(5):1090. https://doi.org/10.3390/biomedicines10051090
Muñiz-Grijalvo O, Diaz-Diaz JL. Quilomicronemia familiar y quilomicronemia multifactorial. Clin Investig Arterioscler. 2021;33(2):56-62.
https://doi.org/10.1016/j.arteri.2021.02.011
Garay-García KJ, Chong-Menendez RJ, Nogueira JP, Piedra-Andrade JS. Síndrome de quilomicronemia familiar: primer caso reportado en Ecuador. Clin Investig Arterioscler. 2022;34(6):326–329. https://doi.org/10.1016/j.arteri.2022.08.002
Witztum JL, Gaudet D, Arca M, Jones A, Soran H, Gouni-Berthold I, et al. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: long-term efficacy and safety data from patients in an open-label extension trial. J Clin Lipidol. 2023;17(3):342–355. https://doi.org/10.1016/j.jacl.2023.03.007
Lahoz C, Mostaza JM. Hipertrigliceridemia familiar/hipertrigliceridemia poligénica. Clin Investig Arterioscler. 2021;33(2):37–42. https://doi.org/10.1016/j.arteri.2020.12.014
Araujo MB, Eiberman G, Etcheverry N, Pacheco G. Síndrome de quilomicronemia familiar: experiencia pediátrica en Argentina. Arch Argent Pediatr. 2022;120(3):e123-e127. https://doi.org/10.5546/aap.2022.e123
Molina-de Salazar DI, Villar-Moya R, Villar-Henríquez M, Murillo-Aranguren MC. Hipertrigliceridemia grave y síndrome de quilomicronemia familiar: una revisión de la literatura reciente. Rev Colomb Cardiol. 2021;28(3):274-283. https://doi.org/10.24875/RCCAR.M21000053
Colaço I, Araújo F, Aguiar P, Cruz D, Bourbon M, Sequeira Duarte J, et al. Síndrome de quilomicronemia familiar: algoritmo diagnóstico. RPMI. 2021;28(4):369–377. https://doi.org/10.24950/rspmi.r.92.4.2021
Quiroga-Padilla PJ, Gaete PV, Mendevil CO. Quilomicronemia familiar. Medicina 2020;80(4):348.358. http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802020000600348
van Hoek M, Dallinga-Thie GM, Steyerberg EW, Sijbrands EJGG. Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes. Eur J Hum Genet. 2009;17(11):1386-1393. https://doi.org/10.1038/ejhg.2009.61
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Revista Colombiana de Endocrinología, Diabetes & Metabolismo